首站-论文投稿智能助手
典型文献
Response to pretransplant downstaging therapy predicts patient outcome after liver transplantation for hepatocellular carcinoma with portal vein tumor thrombus
文献摘要:
To the Editor: Downstaging therapy has been confirmed to help patients whose tumors are beyond the liver transplantation(LT)crite-ria to gain the opportunity for LT with long-term survival.Zhan et al.[1]recently demonstrated that patients with hepatocellular carcinoma(HCC)beyond the Hangzhou criteria on initial diagno-sis without extrahepatic metastasis or vascular invasion have com-parative outcomes with those matching Milan criteria after LT if these patients are successfully downstaged to the Hangzhou crite-ria[1].However,whether the downstaging therapy prolongs the survival time of those with portal vein tumor thrombosis(PVTT)is not clear.Our study was to add some data in this field.
文献关键词:
作者姓名:
Zhe Yang;Jing-Qi Sun;Shuo Wang;Li Zhuang;Shu-Sen Zheng
作者机构:
Department of Hepatobiliary and Pancreatic Surgery,Department of Liver Transplantation,Shulan(Hangzhou)Hospital,Zhejiang Shuren University School of Medicine,Hangzhou 310022,China;Division of Hepatobiliary Pancreatic Surgery,First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China
引用格式:
[1]Zhe Yang;Jing-Qi Sun;Shuo Wang;Li Zhuang;Shu-Sen Zheng-.Response to pretransplant downstaging therapy predicts patient outcome after liver transplantation for hepatocellular carcinoma with portal vein tumor thrombus)[J].国际肝胆胰疾病杂志(英文版),2022(03):295-298
A类:
pretransplant,downstaging, Downstaging,crite,diagno,downstaged
B类:
Response,therapy,predicts,after,liver,transplantation,hepatocellular,carcinoma,portal,vein,thrombus,To,Editor,has,been,confirmed,help,patients,whose,tumors,are,beyond,LT,gain,opportunity,term,survival,Zhan,recently,demonstrated,that,HCC,Hangzhou,criteria,initial,without,extrahepatic,metastasis,vascular,invasion,have,parative,outcomes,those,matching,Milan,if,these,successfully,However,whether,prolongs,thrombosis,PVTT,not,clear,Our,study,was,add,some,data,this,field
AB值:
0.524677
相似文献
Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis
Haoran Mu;Dongqing Zuo;Jie Chen;Zhigang Liu;Zhuo Wang;Liu Yang;Qihui Shi;Yingqi Hua-Shanghai Bone Tumor Institute and Department of Orthopedics,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200080,China;Key Laboratory of Systems Biomedicine(Ministry of Education),Shanghai Center for Systems Biomedicine,Shanghai Jiao Tong University,Shanghai 200240,China;Shanghai Key Laboratory of Medical Epigenetics and the International Co-laboratory of Medical Epigenetics and Metabolism(MOST),Institutes of Biomedical Sciences,Fudan University,Shanghai 200032,China;Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer(SMHC)and Institute of Fudan-Minhang Academic Health System,Minhang Hospital,Fudan University,Shanghai 201199,China;Shanghai Engineering Research Center of Biomedical Analysis Reagents,Shanghai 201203,China
Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy
Shen Junyi;Qi Weili;Dai Junlong;Leng Shusheng;Jiang Kangyi;Zhang Yu;Ran Shun;Li Chuan;Wen Tianfu-Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Laboratory of Liver Transplantation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Chengdu University, Chengdu, Sichuan 610072, China;Department of Hepatobiliary and Pancreatic Surgery, The People's Hospital of Leshan, Leshan, Sichuan 614700, China;Department of Hepatobiliary Surgery, Sichuan Provincial People's Hospital, Chinese Academy of Sciences, Chengdu, Sichuan 610072, China;Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou 550000, China
A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients
Zheng Xiang;Zhang Weijie;Zhou Hua;Cao Ronghua;Shou Zhangfei;Zhang Shuwei;Cheng Ying;Chen Xuchun;Ding Chenguang;Tang Zuofu;Li Ning;Shi Shaohua;Zhou Qiang;Chen Qiuyuan;Chen Gang;Chen Zheng;Zhou Peijun;Hu Xiaopeng;Zhang Xiaodong;Na Ning;Wang Wei-Department of Urology, Capital Medical University Beijing Chaoyang Hospital, Beijing 100020, China;Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430032, China;Kidney Transplantation Dialysis Center, The Second People’s Hospital of Shanxi Province, Taiyuan, Shanxi 030012, China;Department of Organ Transplantation, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong 510120, China;Department of Nephrology, Shulan (Hangzhou) Hospital, Hangzhou, Zhejiang 310000, China;Department of Urology, Ningbo Yinzhou Number. 2 Hospital, Ningbo, Zhejiang 315000, China;Department of Organ Transplantation, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China;Institute of Kidney Transplantation, The First Affiliated Hospital, Medical College of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China;Department of Kidney, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China;Department of Kidney, Southwest Hospital, The First Hospital Affiliated to The Third Military Medical University (Army Medical University), Chongqing 400000, China;Organ Transplant Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510260, China;Kidney Transplantation Center, Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200000, China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
Global prevalence, mortality, and main risk factors for COVID-19 associated pneumocystosis: A systematic review and meta-analysis
Hossein Khodadadi;Ehsan Ahmadpour;Sanam Nami;Rasoul Mohammadi;Hanieh Hosseini;Mahsa Behravan;Hamid Morovati-Department of Parasitology and Mycology,School of Medicine,Shiraz University of Medical Sciences,Shiraz,Iran;Drug Applied Research Center,Tabriz University of Medical Sciences,Tabriz,Iran;Department of Medical Mycology and Parasitology,School of Medicine,Tabriz University of Medical Sciences,Tabriz,Iran;Department of Medical Parasitology and Mycology,School of Medicine,Isfahan University of Medical Sciences,Isfahan,Iran;Immunology Research Center,Tabriz University of Medical Sciences,Tabriz,Iran;Student Research Committee,Shiraz University of Medical Sciences,Shiraz,Iran
Wenshen Jianpi recipe(温肾健脾方)induced immune reconstruction and redistribution of natural killer cell subsets in immunological non-responders of human immunodeficiency virus/acquired immune deficiency syndrome:a randomized controlled trial
TAO Zhuang;WANG Jian;CHEN Xin;LI Yonghong;YAN Yuguang;ZHANG Ao;ZOU Wen;LIU Ying-Research Center of AIDS Treatment with Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Department of Integrated Traditional Chinese and Wetern Medicine,Kunming Hospital of Traditional Chinese Medicine,Kunming 650000,China;Department of Infection,No.6 People's Hospital of Shenyang City,Shenyang 110006,China;University of Chinese Academy of SoCIal SCIences,Beijing,100102,China
TMEM106A transcriptionally regulated by promoter methylation is involved in invasion and metastasis of hepatocellular carcinoma
Shiming Shi;Biao Wang;Jinglei Wan;Lina Song;Guiqi Zhu;Junxian Du;Luxi Ye;Qianqian Zhao;Jialiang Cai;Qing Chen;Kun Xiao;Jian He;Lei Yu;Zhi Dai-Liver Cancer Institute,Zhongshan Hospital,Fudan University&State Key Laboratory of Genetic Engineering,Fudan University,Shanghai 200032,China;Department of Radiation Oncology,Zhongshan Hospital,Fudan University,Shanghai 200032,China;Department of Pediatric Surgery,the First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China;Department of General Surgery,Zhongshan Hospital(South),Fudan University,Shanghai Public Health Clinical Center,Fudan University,Shanghai 200083,China;Department of Gastrointestinal Surgery,Shandong Provincial Hospital Affiliated to Shandong First Medical University,Jinan 250021,China;Department of Liver Surgery and Transplantation,Liver Cancer Institute,Zhongshan Hospital,Fudan University,Shanghai 200032,China
Bone metastasis of hepatocellular carcinoma:facts and hopes from clinical and translational perspectives
Zhao Huang;Jingyuan Wen;Yufei Wang;Shenqi Han;Zhen Li;Xuemei Hu;Dongling Zhu;Zhenxiong Wang;Junnan Liang;Huifang Liang;Xiao-ping Chen;Bixiang Zhang-Hepatic Surgery Center,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Clinical Medical Research Center of Hepatic Surgery at Hubei Province,Wuhan 430030,China;Hubei Key Laboratory of Hepato-Pancreatic-Biliary Diseases,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Radiology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Nuclear Medicine and PET Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Radiology,Guangzhou First People's Hospital,School of Medicine,South China University of Technology,Guangzhou 510180,China;Key Laboratory of Organ Transplantation,Ministry of Education;Key Laboratory of Organ Transplantation,National Health Commission;Key Laboratory of Organ Transplantation,Chinese Academy of Medical Sciences,Wuhan 430030,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。